Search
Pacific Biosciences of California Inc
PACBAdd to Watchlist
1.350USD
+0.050+3.85%
Close 09-14 16:00（ET）
418.04MMarket Cap
LossP/E TTM
Pacific Biosciences of California Inc (PACB) Stock Price Target & Forecast
Analyst Rating
Based on 8 analysts giving stock ratings to Pacific Biosciences of California Inc in the past month.
Buy
2 Strong Buy
2 Buy
3 Hold
1 Sell
0 Strong Sell
Target Price
2.157USD+65.93%
PACB Analyst Recommendation Trends
In the current month, PACB has received 2 Buy Ratings, 3 Hold Ratings, and 1 Sell Ratings. PACB average Analyst price target in the last month is 2.157.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
2
2
2
2
2
2
2
1
2
2
2
2
2
2
2
2
3
3
3
4
5
5
6
6
0
0
0
0
0
0
0
0
1
1
1
1
1
1
0
0
8
8
8
9
10
10
10
9
PACB Analyst Rating for Peer Comparison
Updated: Sep 14, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Intuitive Surgical Inc
ISRG
10
14
9
1
0
34
Boston Scientific Corp
BSX
11
17
6
0
0
34
Thermo Fisher Scientific Inc
TMO
10
18
5
0
0
33
Edwards Lifesciences Corp
EW
10
13
9
0
0
32
Veeva Systems Inc
VEEV
7
15
8
1
0
31
Danaher Corp
DHR
11
13
4
0
0
28
Waters Corp
WAT
8
10
9
0
0
27
Agilent Technologies Inc
A
6
11
7
0
0
24
Resmed Inc
RMD
3
7
11
1
1
23
GE Healthcare Technologies Inc
GEHC
6
8
8
0
0
22
Financial Forecasting
Based on analysts' estimates, PACB EPS is projected to reach -0.152 in FY2026Q3, following reported EPS of -0.144 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.15
-0.13
-0.13
-0.15
-0.13
Actual
-0.13
-0.03
-0.14
--
--
Surprise
+9.35%
+79.93%
-13.22%
--
--
FAQs
What is Pacific Biosciences of California Inc's expected revenue for the next quarter?
Pacific Biosciences of California Inc's expected revenue is 40.41M.
What is Pacific Biosciences of California Inc's price target?
Analysts forecast that Pacific Biosciences of California Inc's price target is USD 2.16, with the highest forecast at USD 3.00 and the lowest forecast at USD 1.25.
How have Pacific Biosciences of California IncPACB's recent earnings per share performed?
The market expectation was USD -0.14, while Pacific Biosciences of California IncPACB's earnings per share (EPS) for the previous quarter was USD -0.03. EPS for the next quarter is expected at USD -0.15.
What is the analyst rating for Pacific Biosciences of California Inc?
Based on the ratings of Pacific Biosciences of California Inc's stock from 8 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.